https://doi.org/10.1038/s41531-021-00263-x
C
Clelia Di Salvo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
255
Citations
10
h-index
10
i10-index
Clelia Di Salvo is an academic researcher from University of Pisa. The author has contributed to research in topics: Gut microbiota and health & Diet and metabolism studies & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 10, co-authored 33 publications.
ORCID: 0009-0002-7083-4214Papers by this author
worksEnteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
2022 · npj Parkinson s Disease · 78 citations
RETRACTED ARTICLE: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis
2022 · Inflammation · 21 citations
https://doi.org/10.1007/s10753-022-01663-8
Su1241 EVALUATION OF THE BENEFICIAL EFFECTS OF A PRODUCT CONTAINING GAMMA-AMINOBUTYRIC ACID (GABA) IN POSTINFLAMMATORY IRRITABLE BOWEL SYNDROME: A PRECLINICAL STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02096-1
732 EFFECTS OF PROBIOTIC MIXTURE STANDARDIZED WITH MALTODEXTRIN ON COLONIC DYSMOTILITY AND ENTERIC INFLAMMATION IN A SPONTANEOUS MODEL OF ACCELERATE SENESCENCE
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)00901-6
Sa1697 GUT PERMEABILITY AND ITS ROLE IN PARKINSON'S DISEASE: PRELIMINARY RESULTS FROM A PILOT STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)01582-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat